Drug Shortage Report for APO-OLMESARTAN/HCTZ

Last updated on 2018-04-23 History
Report ID 16905
Drug Identification Number 02453614
Brand name APO-OLMESARTAN/HCTZ
Common or Proper name OLMESARTAN-HCTZ
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL
Strength(s) 12.5MG 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 30 BLS
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-18
Estimated end date 2018-04-30
Actual end date 2018-04-20
Shortage status Resolved
Updated date 2018-04-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2018-04-23 French Compare
v23 2018-04-23 English Compare
v22 2018-02-13 French Compare
v21 2018-02-13 English Compare
v20 2018-02-12 French Compare
v19 2018-02-12 English Compare
v18 2018-01-16 French Compare
v17 2018-01-16 English Compare
v16 2017-12-20 French Compare
v15 2017-12-20 English Compare
v14 2017-11-29 French Compare
v13 2017-11-29 English Compare
v12 2017-11-27 French Compare
v11 2017-11-27 English Compare
v10 2017-10-04 French Compare
v9 2017-10-04 English Compare
v8 2017-08-16 French Compare
v7 2017-08-16 English Compare
v6 2017-08-14 French Compare
v5 2017-08-14 French Compare

Showing 1 to 20 of 24